Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

(NQ: )

N/A UNCHANGED
Last Price Updated: Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about

< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
5 Biotechnology Stocks to Buy Now
 
Tags NASDAQ:INCY NASDAQ:LJPC NASDAQ:CLDN
From InvestorPlace
6 Biotechnology Stocks to Buy Now
 
Tags NASDAQ:IDIX Stocks to Buy NASDAQ:PGNX
From InvestorPlace
6 Biotechnology Stocks to Buy Now
 
Tags NASDAQ:INCY NASDAQ:CLDN NASDAQ:LJPC
From InvestorPlace
6 Biotechnology Stocks to Buy Now
 
Tags NASDAQ:LJPC NASDAQ:CLDN NASDAQ:INCY
From InvestorPlace
Armetheon Raises $24.3 Million From Taiwan/China Investors
Armetheon, a San Francisco area specialty biopharma, raised $24.3 million in a Series B funding that will be used to underwrite a Phase III trial of its oral anticoagulant, tecarfarin. Participants in... 
From ChinaBio® Today
What Investors Are Watching For In Regulus Therapeutics' Next Data Release
Biotech companies that treat Hepatitis C were on fire in 2014. The leader of the pack, Gilead Sciences, Inc. (NASDAQ: GILD), had the ... 
Tags ENTA MRK RGLS
From Benzinga
Biotech ETFs Hitting New Highs On Takeover News (FBT, PBE, ITMN)
The biotechnology industry had a big day Monday after the news of Swiss pharmaceutical giant Roche agreed to acquire the U.S biotech ... 
Tags PBE IDIX FBT
From Benzinga
UPDATE: Deutsche Bank Initiates Coverage On Merck
Deutsche Bank initiated coverage of Merck (NYSE: MRK) with a Hold rating and price target of $63. Analyst Gregg Gilbert outlined ... 
Tags Initiation Gregg Gilbert Analyst Ratings
From Benzinga
There's still hunger for 'blockbuster' biotech deals
Roche's $8.3 billion deal for InterMune is one of the few this year that returns to the traditional model of big pharma buying smaller biotech. 
Tags Health Care IT Johnson and Johnson Roche Holding AG
From CNBC.com News
Ukraine Tension Prominent As Dow Suffers Triple Point Digit Loss; S&P 500 & Nasdaq Also Lower
U.S. stocks declined and erased Monday's gains following reports that Russian troops were lining on the borders of Ukraine ... 
Tags ODP WAG CVS
From Benzinga
Hottest Healthcare Stocks Now – SHPG ISRG AGN IDIX
 
Tags NYSE:AGN NYSE:LCI NASDAQ:IDIX
From InvestorPlace
Exclusive: Enanta Pharmaceuticals CEO Jay Luly Discusses Hep C Pipeline
The hepatitis C industry has been on fire since Merck (NYSE: MRK) paid a 230 percent premium for pharmaceutical company Idenix (NASDAQ: ... 
Tags ACHN Health Care Enata Pharmaceuticals
From Benzinga
Exclusive: Hepatitis C Stock Valuation With Enanta CEO Jay Luly
Merck (NYSE: MRK) paid a 230 percent premium for Hepatitis C-focused Idenix Pharmaceuticals (NASDAQ: IDIX). News of the massive ... 
Tags Interview biotechnology IDIX
From Benzinga
Idenix Pharmaceuticals Stock Sees Short Interest Fall 16%
The most recent short interest data has been released by the NASDAQ for the 06/13/2014 settlement date, which shows a 3,181,609 share decrease in total short interest for Idenix Pharmaceuticals Inc... 
Tags Stocks
From Market News Video
Market Wrap For June 20: Yet Again, Dow And S&P 500 Indices Hit New Highs
U.S. stocks were slightly higher as the Dow and S&P 500 indices continue hitting new all-time highs following positive comments ... 
Tags encana DECK KORS
From Benzinga
Baird Comments On Achillion's Bullish Share Action
Baird analyst Brian Skorney reported on “increasingly bullish” share action of Achillion Pharmaceuticals (NASDAQ: ACHN) ... 
Tags ACHN Brian Skorney Price Target
From Benzinga
Noteworthy ETF Inflows: XBI, IDIX, ACHN, MNKD
Symbols mentioned in this story: XBI, IDIX, ACHN, MNKD Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These... 
Tags ETFs
From ETF Channel
Biotech ETFs – Keep Those Buyouts Coming!
 
Tags ETF Investing NASDAQ:IDIX NYSEARCA:XBI
From InvestorPlace
Investors eye Achillion for next big pharma deal
Achillion's been a takeover target for years. But Merck's acquisition of Idenix may mean Achillion's time has come. 
Tags Achillion Pharmaceuticals Inc/ Merck & Co Inc Biotechnology
From CNBC.com News
CORRECTED-US STOCKS-Wall St edges up, lifted by mergers, acquisitions
(Fixes Rex Macey's job title and firm's name, which both changed recently, to chief allocation officer at Wilmington Trust Investment Advisors from chief investment officer at Wilmington Trust, in this... 
Tags companyNews
From Reuters: Company News
ETF Outlook For Tuesday, June 10, 2014 (IAT, FXE, PBE, HYHG, IDIX, MRK)
ETF Outlook for Tuesday, June 10, 2014 iShares Dow Jones U.S. Regional Banks ETF (NYSE: IAT) The strong sector Monday was the ... 
Tags FXE Pre/Market Outlook IAT
From Benzinga
UPDATE: Morgan Stanley Reiterates On Idenix Pharmaceuticals Due To Likely Merck Acquisition
In a report published Tuesday, Morgan Stanley analyst David Friedman reiterated an Equal-Weight rating on Idenix Pharmaceuticals ... 
Tags David Friedman Analyst Color Price Target
From Benzinga
Achillion shares up; FDA lifts hold on hepatitis C drug
News comes a day after Merck said it is buying Idenix, another company developing HCV drugs. 
Tags General MRK Health/Care
From MarketWatch
US STOCKS-Futures dip, S&P 500 comes off 4th straight record
NEW YORK, June 10 (Reuters) - U.S. stock index futures edged lower on Tuesday, as investors found few reasons to keep buying with the Dow and S&P 500 just off the latest in a string of records. 
Tags companyNews
From Reuters: Company News
Investors mull upbeat China data ahead of US open
U.S. stock index futures pointed to a lower start to Wall Street trade on Tuesday, despite more upbeat news out of China. 
Tags Investing/Stock Market DJIA tvcodes/tvecon
From CNBC.com News
PRESS DIGEST- New York Times business news - June 10
June 10 (Reuters) - The following are the top stories on the New York Times business pages. Reuters has not verified these stories and does not vouch for their accuracy. 
Tags companyNews
From Reuters: Company News
PRESS DIGEST-Wall Street Journal - June 10
June 10 (Reuters) - The following are the top stories in the Wall Street Journal. Reuters has not verified these stories and does not vouch for their accuracy. 
Tags companyNews
From Reuters: Company News
Asia stocks called up; China data in focus
Asian shares are called higher on Tuesday following yet another record close on Wall Street, with attention turning to Chinese inflation figures. 
Tags DJIA S&P 500 Merck & Co Inc
From CNBC.com News
Benzinga's M&A Chatter for Monday June 9, 2014
The following are the M&A deals, rumors and chatter circulating on Wall Street for Monday June 9, 2014: Merck to Acquire Idenix for ... 
Tags MRK PPC TSN
From Benzinga
US STOCKS-Dow, S&P 500 extend string of record closes; VIX up
* International Game Technology shares fly after Reuters report 
Tags companyNews
From Reuters: Company News
< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.